Reeflex Solutions (TSXV:RFX) Announces Filing Deadline Delay and Restatement of Financials

Calgary, Alberta — December 18, 2025 — Leads & Copy — Reeflex Solutions Inc. (TSXV: RFX) announced it will not meet the December 29, 2025, filing deadline for its audited annual financial statements, accompanying management’s discussion and analysis (MD&A), and CEO and CFO certifications for the financial year ended August 31, 2025.

The company also intends to restate its interim financial statements for the quarter ended May 31, 2025, accompanying MD&A and certifications. These filings are required pursuant to National Instrument 51-102 Continuous Disclosure Obligations, and National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings.

The delay is attributed to the complexity of the company’s audit process and the transition from a privately held, family-owned operating business to a fully IFRS-compliant public company. This follows the completion of its reverse takeover transaction on May 16, 2025, and the related acquisition of Coil Solutions Inc. (CSI) on May 15, 2025.

Concurrent with the transaction, the company changed its year-end from December 31, 2025, to August 31, 2025, to align with CSI’s year-end, and engaged MNP LLP as its new auditor.

The company’s previously filed Q3 filings were prepared based on CSI’s operating results for the full quarter. Following discussions with its auditor, Reeflex determined that the Q3 filings must be restated to reflect CSI’s results only from the May 15, 2025, acquisition date, in accordance with IFRS.

The company is working with its auditor to complete the required filings as soon as practicable and expects to complete them on or about January 29, 2026.

Reeflex has applied to the Alberta Securities Commission (ASC) for a Management Cease Trade Order (MCTO). If granted, the MCTO will restrict the company’s CEO and CFO from trading in its securities until the required filings are made but will not affect the ability of the general investing public to trade in the company’s common shares.

The company intends to satisfy the provisions of the alternative information guidelines set out in NP 12-203 and will issue biweekly default status reports in the form of further news releases. There are no insolvency proceedings against it as of the date of this release, and there is no other material information concerning the affairs of the company that has not been generally disclosed.

The restatement of the Q3 filings is technical and accounting-related and does not impact the company’s core operations, customer relationships, order backlog, manufacturing activity, or business momentum. On December 1, 2025, the company announced the receipt of $2.6 million in purchase orders for products to be deployed in Saudi Arabia, and on December 11, 2025, the company announced the award of a $3.4 million contract to design and manufacture products for an existing customer.

Reeflex is generating revenue, actively pursuing the development of existing and new products, and has sufficient working capital to fund its day-to-day operations.

Reeflex Solutions Inc. delivers advanced engineering and manufacturing solutions across various industry sectors. Through its wholly-owned subsidiary, Coil Solutions Inc., it provides coiled tubing injectors and downhole tools for the oil & gas sector. Its manufacturing division, Ranglar Manufacturing, specializes in custom-designed mobile equipment for a wide range of industrial applications.

Trevor Conway
Executive Vice President & CFO
(403) 605-6167
Trevor.Conway@Reeflex.ca

Source: Reeflex Solutions Inc.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.